socalTECH

SEPTEMBER 1, 2016

Thousand Oaks-based Amgen and Boehringer Ingelheim said on Thursday that Amgen has acquired the global development and commercial rights for an immuno-oncology drug for treating multiple myeloma. The compound is currently in Phase I studies. Financial details of the deal were not announced. READ MORE>>.

Thousand Oaks 113

Thousand Oaks Study Develop Development 113

Xconomy

JULY 18, 2016

The company is developing a nasal formulation of metoclopramide, , an already-approved treatment for digestive pain and other symptoms related to the stomach being unable to empty its contents. Evoke’s late-stage study failed to show a significant benefit to the drug, EVK-001, versus placebo at all 41 of the sites that tested it nationally.

Study 40

Study Sites News Research 40

Xconomy

SEPTEMBER 7, 2016

Retrophin , the drug developer founded by controversial former biotech executive Martin Shkreli, has posted positive results from a midstage study for its treatment for a rare kidney disease. He licensed the drug from San Diego-based Ligand Pharmaceuticals (NASDAQ: LGND ) in March 2012. to $30 apiece.

San Diego 40

San Diego Pricing Study Journal 40

Tech Zulu Event

FEBRUARY 3, 2014

I’ve been an avid user of Plug.DJ’s music discovery site since early 2012, have discovered a ton of music there (which, by the way, I’m still listening to today) and originally covered their $1.25M in seed-round funding from Javelin Venture Partners. was founded in February 2012 by a team of passionate music fans.

Startup 107

Startup Product Sites Tool 107